- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis ; volume:21 ; number:1 ; day:10 ; month:7 ; year:2021 ; pages:1-10 ; date:12.2021
BMC pulmonary medicine ; 21, Heft 1 (10.7.2021), 1-10, 12.2021
- Urheber
-
Sugino, Keishi
Ono, Hirotaka
Watanabe, Natsumi
Ando, Masahiro
Tsuboi, Eiyasu
Homma, Sakae
Kishi, Kazuma
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-021-01595-3
- URN
-
urn:nbn:de:101:1-2021101619103846410075
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sugino, Keishi
- Ono, Hirotaka
- Watanabe, Natsumi
- Ando, Masahiro
- Tsuboi, Eiyasu
- Homma, Sakae
- Kishi, Kazuma
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis